| Company Name | Recode Therapeutics UK Limited |
|---|---|
| Director | Shehnaaz Suliman |
| Company Status | Active |
| Company Number | 14646958 |
| Category | Private Limited Company |
| Incorporation Date | 8 February 2023(1 year, 3 months ago) |
Business Activity
| Section M | Professional, scientific and technical activities |
|---|---|
| SIC 7499 | Non-trading company non trading |
| SIC 74990 | Non-trading company non trading |
Directors
| Director Name | Shehnaaz Suliman |
|---|---|
| Date of Birth | July 1971 (Born 52 years ago) |
| Nationality | American |
| Status | Current |
| Appointed | 08 February 2023(same day as company formation) |
| Role | Biotech Chief Executive Officer |
| Country of Residence | United States |
| Correspondence Address | Suite 1, 7th Floor 50 Broadway London SW1H 0DB |
| Secretary Name | Stanley Max Barker Jr. |
|---|---|
| Status | Current |
| Appointed | 08 February 2023(same day as company formation) |
| Role | Company Director |
| Correspondence Address | Suite 1, 7th Floor 50 Broadway London SW1H 0DB |
Location
| Registered Address | 1 Cork Street Mews London W1S 3BL |
|---|---|
| Region | London |
| Constituency | Cities of London and Westminster |
| County | Greater London |
| Ward | West End |
| Built Up Area | Greater London |
| Address Matches | 6 other UK companies use this postal address |
Accounts
| Next Accounts Due | 8 November 2024 (5 months, 4 weeks from now) |
|---|---|
| Accounts Category | No Accounts Filed |
| Accounts Year End | 28 February |
Returns
| Latest Return | 7 February 2024 (3 months ago) |
|---|---|
| Next Return Due | 21 February 2025 (9 months, 2 weeks from now) |
Filing History
| 23 April 2024 | Registered office address changed from Suite 1, 7th Floor 50 Broadway London SW1H 0DB United Kingdom to 1 Cork Street Mews London W1S 3BL on 23 April 2024 (1 page) |
|---|---|
| 9 April 2024 | Confirmation statement made on 7 February 2024 with no updates (3 pages) |
| 8 February 2023 | Incorporation Statement of capital on 2023-02-08
|